BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26540372)

  • 1. Short- and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours: analyses according to the WHO 2010 classification.
    Nakamura K; Osada M; Goto A; Iwasa T; Takahashi S; Takizawa N; Akahoshi K; Ochiai T; Nakamura N; Akiho H; Itaba S; Harada N; Iju M; Tanaka M; Kubo H; Somada S; Ihara E; Oda Y; Ito T; Takayanagi R
    Scand J Gastroenterol; 2016; 51(4):448-55. PubMed ID: 26540372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of endoscopic resection for duodenal neuroendocrine tumors.
    Yi K; Kim GH; Kim SJ; Choi CW; Lee MW; Lee BE; Song GA
    Sci Rep; 2023 Oct; 13(1):17908. PubMed ID: 37863959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic submucosal dissection for rectal neuroendocrine tumours: A multicentric retrospective study.
    Rimondi A; Despott EJ; Chacchi R; Lazaridis N; Costa D; Bucalau AM; Mandair D; Pioche M; Rivory J; Santos-Antunes J; Marques M; Ramos-Zabala F; Barbaro F; Pimentel-Nunes P; Dinis-Ribeiro M; Albeniz E; Tantau M; Spada C; Lemmers A; Caplin M; Toumpanakis C; Murino A
    Dig Liver Dis; 2024 May; ():. PubMed ID: 38763794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors.
    Esposito G; Dell'Unto E; Ligato I; Marasco M; Panzuto F
    Expert Rev Gastroenterol Hepatol; 2023; 17(8):785-793. PubMed ID: 37497604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing risk stratification in long-term outcomes of rectal neuroendocrine tumors following endoscopic resection: a multicenter retrospective study.
    Lee HJ; Seo Y; Oh CK; Lee JM; Choi HH; Gweon TG; Lee SH; Cheung DY; Kim JI; Park SH; Lee HH
    Scand J Gastroenterol; 2024 Apr; ():1-7. PubMed ID: 38587111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric Neuroendocrine Tumors According to the 2019 World Health Organization Grading System: A Single-Center, Retrospective Study.
    Kim Y; Ahn B; Choi KD; Kim BS; Yook JH; Lee GH; Hong SM; Lee JH
    Gut Liver; 2023 Nov; 17(6):863-873. PubMed ID: 36588525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours.
    Rinke A; Ambrosini V; Dromain C; Garcia-Carbonero R; Haji A; Koumarianou A; van Dijkum EN; O'Toole D; Rindi G; Scoazec JY; Ramage J
    J Neuroendocrinol; 2023 Jun; 35(6):e13309. PubMed ID: 37345509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
    Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
    Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nationwide, multi-institutional collaborative retrospective study of colorectal neuroendocrine tumors in Japan.
    Yamaguchi T; Takahashi K; Yamada K; Bando H; Baba H; Ito M; Funahashi K; Ueno H; Fujita S; Hasegawa S; Sakai Y; Sugihara K
    Ann Gastroenterol Surg; 2021 Mar; 5(2):215-220. PubMed ID: 33860141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic Management of Gastro-Entero-Pancreatic Neuroendocrine Tumours: An Overview of Proposed Resection and Ablation Techniques.
    Chacchi-Cahuin R; Despott EJ; Lazaridis N; Rimondi A; Fusai GK; Mandair D; Anderloni A; Sciola V; Caplin M; Toumpanakis C; Murino A
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study.
    Mekkan-Bouv Hez M; Derbey L; de Mestier L; D L; Walter T; Perrier M; Cadiot G; Goichot B; Pracht M; Lièvre A; Coriat R; Valancot S; Guimbaud R; Carrere N; Bacoeur-Ouzillou O; Belleannée G; Smith D; Laboureau S; Hescot S; Julie C; Teissier MP; Thereaux J; Ferru A; Evrard C; Mathonnet M; Christou N;
    Int J Surg; 2024 Apr; ():. PubMed ID: 38573078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic intermuscular dissection in the management of a rectal neuroendocrine tumor.
    Liao S; Li B; Huang L; Qiu Q; Yang G; Ren J; Huang S
    Endoscopy; 2023 Dec; 55(S 01):E977-E979. PubMed ID: 37604447
    [No Abstract]   [Full Text] [Related]  

  • 13. Do Rectal Neuroendocrine Tumors with Incomplete Endoscopic Resection for Positive Resection Margin Need Salvage Treatment?
    Wang L; Qiu J; Zhang Y; Pan X
    Am J Gastroenterol; 2024 May; ():. PubMed ID: 38713143
    [No Abstract]   [Full Text] [Related]  

  • 14. Per Anal Endoscopic Myectomy Using a Double-Tunneling Technique for Rectal Neuroendocrine Neoplasm.
    Sako T; Morisawa T; Toyonaga T
    Clin Gastroenterol Hepatol; 2024 Jan; ():. PubMed ID: 38191013
    [No Abstract]   [Full Text] [Related]  

  • 15. Observation for localized, low-grade duodenal neuroendocrine tumors: Equivalent outcomes to resection.
    Kunte AR; Yadav N; Bhandare MS; Puranik A; Bal M; Chaudhari VA; Shrikhande SV
    J Gastrointest Surg; 2024 May; ():. PubMed ID: 38782087
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroendocrine tumors of the gastrointestinal tract and the role of cytotoxic chemotherapy.
    Khasraw M; Ananda S; Michael M
    Expert Rev Anticancer Ther; 2016; 16(4):391-401. PubMed ID: 26808925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic submucosal resection with an endoscopic variceal ligation device for the treatment of rectal neuroendocrine tumors.
    Ebi M; Nakagawa S; Yamaguchi Y; Tamura Y; Izawa S; Hijikata Y; Shimura T; Funaki Y; Ogasawara N; Sasaki M; Joh T; Kasugai K
    Int J Colorectal Dis; 2018 Dec; 33(12):1703-1708. PubMed ID: 30167779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced detection of lymphovascular invasion in small rectal neuroendocrine tumors using D2-40 and Elastica van Gieson immunohistochemical analysis.
    Kitagawa Y; Ikebe D; Hara T; Kato K; Komatsu T; Kondo F; Azemoto R; Komoda F; Tanaka T; Saito H; Itami M; Yamaguchi T; Suzuki T
    Cancer Med; 2016 Nov; 5(11):3121-3127. PubMed ID: 27748061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and Management of Rectal Neuroendocrine Tumors.
    Chablaney S; Zator ZA; Kumta NA
    Clin Endosc; 2017 Nov; 50(6):530-536. PubMed ID: 29207857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms.
    Ramage JK; De Herder WW; Delle Fave G; Ferolla P; Ferone D; Ito T; Ruszniewski P; Sundin A; Weber W; Zheng-Pei Z; Taal B; Pascher A;
    Neuroendocrinology; 2016; 103(2):139-43. PubMed ID: 26730835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.